Porcel Pérez, J. M., Ferreiro, L., Rumi, L., Espino Paisán, E., Civit, C., Pardina Solano, M. A., . . . Bielsa Martín, S. (2020). Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial.
Citación estilo ChicagoPorcel Pérez, José Manuel, Lucía Ferreiro, Laura Rumi, Esther Espino Paisán, Carmen Civit, Marina Asunción Pardina Solano, Joan Antoni Schoenenberger, Luis Valdés, y Silvia Bielsa Martín. Two Vs. Three Weeks of Treatment With Amoxicillin-clavulanate for Stabilized Community-acquired Complicated Parapneumonic Effusions. A Preliminary Non-inferiority, Double-blind, Randomized, Controlled Trial. 2020.
Cita MLAPorcel Pérez, José Manuel, et al. Two Vs. Three Weeks of Treatment With Amoxicillin-clavulanate for Stabilized Community-acquired Complicated Parapneumonic Effusions. A Preliminary Non-inferiority, Double-blind, Randomized, Controlled Trial. 2020.